The ROE as of July 2025 (TTM) for Kadimastem Ltd (KMSTF) is 0.06%

According to Kadimastem Ltd’s latest financial reports and current stock price. The company's current ROE is 0.06%. This represents a change of 99.31% compared to the average of 0.03% of the last 4 quarters.

Kadimastem Ltd (KMSTF) Historical ROE (quarterly & annually)

How has KMSTF ROE performed in the past?

The mean historical ROE of Kadimastem Ltd over the last ten years is -534.02%. The current 0.06% ROE has changed -100.01% with respect to the historical average. Over the past ten years (40 quarters), KMSTF's ROE was at its highest in in the March 2020 quarter at 72.56%. The ROE was at its lowest in in the March 2023 quarter at -2.04%.

Kadimastem Ltd (KMSTF) ROE by Quarter and Year

Discovering the peaks and valleys of Kadimastem Ltd ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Kadimastem Ltd (KMSTF) Average ROE

How has KMSTF ROE performed in the past?

The current ROE of Kadimastem Ltd (KMSTF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Kadimastem Ltd (KMSTF) ROE vs. Peers

How is KMSTF’s ROE compared to its peers?

Kadimastem Ltd’s ROE is greater than Alpha Tau Medical Ltd. (-49.48%), greater than EyePoint Pharmaceuticals, Inc. (-54.27%), less than HCW Biologics Inc. (313.31%), greater than Innate Pharma S.A. (-262.93%), greater than Orchestra BioMed Holdings, Inc. (-189.26%), greater than Virax Biolabs Group Limited (-91.77%), less than Baudax Bio, Inc. (1.07%), greater than YS Biopharma Co., Ltd. (-49.36%), greater than NexImmune, Inc. (-436.50%), less than Altamira Therapeutics Ltd. (783.37%), greater than Blue Water Vaccines, Inc. (-293.56%), greater than Revelation Biosciences, Inc. (-505.44%), greater than Hillstream BioPharma, Inc. (-550.15%), greater than Kiora Pharmaceuticals, Inc. (-42.81%), greater than Compugen Ltd. (-24.51%), greater than BiomX Inc. (-42.20%), less than Pluri Inc. (472.66%), greater than Surface Oncology, Inc. (-61.52%), greater than BioLineRx Ltd. (-23.93%), greater than XBiotech Inc. (-21.14%), greater than Cyteir Therapeutics, Inc. (-26.35%), greater than PMV Pharmaceuticals, Inc. (-32.54%), greater than Graphite Bio, Inc. (-23.74%), greater than Ovid Therapeutics Inc. (-34.13%),

Build a custom stock screener for Kadimastem Ltd (KMSTF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Kadimastem Ltd using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Kadimastem Ltd (KMSTF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Kadimastem Ltd or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.